Moore Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-175,000
| Closed | -$1.04M | – | 592 |
|
|
2020
Q3 | $1.04M | Hold |
175,000
| – | – | 0.02% | 269 |
|
|
2020
Q2 | $466K | Hold |
175,000
| – | – | 0.01% | 212 |
|
|
2020
Q1 | $341K | Buy |
175,000
+125,000
| +250% | +$244K | 0.01% | 133 |
|
|
2019
Q4 | $353K | Hold |
50,000
| – | – | 0.01% | 209 |
|
|
2019
Q3 | $492K | Sell |
50,000
-50,000
| -50% | -$492K | 0.02% | 232 |
|
|
2019
Q2 | $1.14M | Hold |
100,000
| – | – | 0.03% | 221 |
|
|
2019
Q1 | $1M | Buy |
+100,000
| New | +$1M | 0.03% | 222 |
|